Kindred Biosciences, Inc. (NASDAQ: KIN) announced that the U.S. Food and Drug Administration's Center for Veterinary Medicine approved Mirataz ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE